Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

NCT00802594 is registered in ClinicalTrials.gov with Immtech Pharmaceuticals, Inc as lead sponsor.

NCT NCT00802594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00802594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
Lead sponsor
Immtech Pharmaceuticals, Inc
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2001
Completion date
November 30, 2004
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

trypanosomiasis, african